Clariane's Successful €100M Tap Issue Enhances Financial Strength

Successful Tap Issue by Clariane
Clariane has recently announced a significant financial milestone with the completion of a €100 million tap issue of its notes, due on June 27, 2030. This move increases the total outstanding amount to an impressive €500 million. The tap issue is reflective of Clariane’s proactive strategy to maintain and enhance its financial footing within the evolving market landscape.
Details of the Notes
The newly issued notes carry an annual coupon of 7.875%. Clariane seeks to integrate these bonds fully with its existing debt instruments issued on June 27, 2025. By consolidating its notes, the company not only simplifies its debt structure but also showcases confidence in its ongoing operational strategy.
Purpose of the Tap Issue
The net proceeds from this tap issue are earmarked to refinance existing debt, including the intended redemption of OCEANE (Obligations Convertibles en Actions Nouvelles ou Existantes), which is crucial for managing the company’s financial obligations efficiently. This strategic refinancing is planned to bolster Clariane’s overall financial health, enabling the firm to navigate current economic challenges more effectively.
Market Reception and Future Prospects
Upon successful completion, these notes will be submitted for trading on the Global Exchange Market of Euronext Dublin, with settlement expected to occur shortly. This is an encouraging sign for investors, affirming Clariane’s robust operational capabilities and signaling potential for growth in the near future.
Leadership Insight
The tap issue was coordinated by Morgan Stanley acting as Sole Global Coordinator and Active Bookrunner. Their leadership in this process exemplifies confidence in Clariane’s strategy and future growth. Engaging with top-tier financial partners underscores the company’s commitment to optimizing its capital structure.
About Clariane
Clariane stands at the forefront of the European care community, providing essential services during vulnerable times. With operations spanning six countries, it engages a workforce of approximately 63,000 professionals, delivering care to nearly 900,000 patients and residents. Their diverse service offerings include care homes, healthcare facilities, and alternative living solutions, meeting the varied needs of the population.
As of June 2023, Clariane has embraced its role with a renewed purpose, focusing on “taking care of each person’s humanity in times of vulnerability.” The company continues to be listed on Euronext Paris since November 2006, having joined prestigious indexes such as SBF 120 and CAC® SBT 1.5 notably in September 2024.
Contact Information
For further inquiries or investment-related questions, please reach out to:
Stéphane Bisseuil
Head of Investor Relations
Phone: +33 6 58 60 68 69
stephane.bisseuil@clariane.com
Benoît Lesieur
Deputy Head of Investor Relations – ESG
Phone: +33 6 64 80 15 90
benoit.lesieur@clariane.com
Julie Mary
Press Officer
Phone: +33 6 59 72 50 69
julie.mary@clariane.com
Florian Bachelet
Press Officer
Phone: +33 6 79 86 78 23
florian.bachelet@clariane.com
Frequently Asked Questions
What is the amount of the recent tap issue by Clariane?
Clariane recently completed a tap issue of €100 million, bringing the total amount of its notes to €500 million.
What is the maturity date of the notes issued by Clariane?
The notes are due on June 27, 2030.
What will the proceeds from the tap issue be used for?
The net proceeds will be used to refinance existing debt, including the redemption of OCEANE.
Who coordinated the tap issue for Clariane?
Morgan Stanley acted as the Sole Global Coordinator and Active Bookrunner for this tap issue.
What is Clariane's corporate purpose?
Clariane focuses on "taking care of each person’s humanity in times of vulnerability" as part of its corporate mission.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.